|
Re: Now is the time over late spring and summer
|
2
|
Resverlogix Corp.
|
May 16, 2018 10:17AM
|
|
Re: Now following.
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 08, 2019 10:47AM
|
|
Re: November 8, 2016, Resverlogix presented at BIO Europe in Cologne, Germany.
|
2
|
Resverlogix Corp.
|
Nov 10, 2016 01:15PM
|
|
Re: Novartis' canakinumab (Ilaris)
|
7
|
Resverlogix Corp.
|
Mar 13, 2018 03:20PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
2
|
Resverlogix Corp.
|
Aug 29, 2017 08:37PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
5
|
Resverlogix Corp.
|
Jun 22, 2017 11:46AM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
4
|
Resverlogix Corp.
|
Jun 22, 2017 01:06PM
|
|
Re: Novartis & Pfizer withdraw drug application in Europe
|
3
|
Resverlogix Corp.
|
Dec 23, 2018 11:01AM
|
|
Re: Notice of Meeting and Management Information Circular Posted
|
3
|
Zenith Epigenetics
|
Sep 28, 2019 07:53AM
|
|
Re: Notice of Meeting and Management Information Circular Posted
|
3
|
Resverlogix Corp.
|
Sep 28, 2019 07:54AM
|
|
Re: Notice of Meeting and Information Circular on SEDAR
|
4
|
Resverlogix Corp.
|
Aug 11, 2018 12:43PM
|
|
Re: Notice of Meeting and Information Circular on SEDAR
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 01:29PM
|
|
Re: Notice of Annual and Special Meeting on September 30th 2015
|
4
|
Resverlogix Corp.
|
Jul 20, 2015 06:16PM
|
|
Re: Nothing yet
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 07:54AM
|
|
Re: Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 16, 2016 10:26AM
|
|
Re: Notes from the Zenith Corporate Update
|
5
|
Zenith Epigenetics
|
Dec 16, 2016 11:41AM
|
|
Re: Note from Sarah Re: Orphan etc.....
|
3
|
Resverlogix Corp.
|
Jun 30, 2015 10:11PM
|
|
Re: Note from Sarah Re: Orphan etc.....
|
3
|
Resverlogix Corp.
|
Jul 01, 2015 11:04AM
|
|
Re: Note from Sarah Re: Orphan etc.....
|
2
|
Resverlogix Corp.
|
Jun 30, 2015 02:43PM
|
|
Re: Not quite a breakout yet....
|
9
|
Resverlogix Corp.
|
Apr 20, 2019 05:46PM
|
